Is gastrinoma a medical disease?

Yale Journal of Biology and Medicine

Volumn 69, Issue 3, 1996, Pages 289-300

  Mignon, M ^a   Cadiot, G ^a   Marmuse, J P ^a   Lewin, M J M ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROZOTOCIN; DOXORUBICIN; FLUOROURACIL; HISTAMINE H2 RECEPTOR ANTAGONIST; INTERFERON; OCTREOTIDE; PENTETREOTIDE IN 111; PROTON PUMP INHIBITOR; SOMATOSTATIN DERIVATIVE; STOMACH SECRETION INHIBITOR; STREPTOZOCIN;

BONE METASTASIS; CLINICAL FEATURE; DIAGNOSTIC IMAGING; GASTRINOMA; HUMAN; LAPAROTOMY; LIVER METASTASIS; LIVER RESECTION; LIVER TRANSPLANTATION; LYMPH NODE METASTASIS; MULTIPLE ENDOCRINE NEOPLASIA; REVIEW; SURVIVAL RATE; ZOLLINGER ELLISON SYNDROME;

ENDOSCOPY; GASTRINOMA; HUMANS; ZOLLINGER-ELLISON SYNDROME;

EID: 0030427967     PISSN: 00440086     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (45)

1. Mignon, M., Ruszniewski, Ph., Haffar, S., Rigaud, D., René, E., and Bonfils, S. Current approach to the management of tumoral process in patients with gastrinoma. World J. Surg. 10:703-710, 1986.
2. Jensen, R.T., Doppman, J.L., and Gardner, J.D. Gastrinoma. In: Go, V.L.W., Gardner, J.D., Brooks, F.P., Dimagno, E., Lebenthal, E., and Scheele, G.S., eds. The exocrine pancreas : biology, pathobiology and diseases. Edinburg: Raven Press; 1986, pp. 727-744.
3. Norton, J.A. Surgical treatment of islet cell tumors with special emphasis on operative ultrasound. In: Mignon, M. and Jensen, R.T., eds. Endocrine tumors of the pancreas. Basel: Karger, Front. Gastrointest. Res.; 1995, pp. 309-332.
4. Bonfils, S., Landor, J.H., Mignon, M., and Hervoir, P. Results of surgical management in 92 consecutive patients with Zollinger-Ellison syndrome. Ann. Surg. 194:692-697, 1981.
5. Malagelada, J.F., Edis, A.J., Adson, M.A., Van Heerden, J.A., and Go, V.L.W. Medical and surgical options in the management of patients with gastrinoma. Gastroenterology 84:1524-1532,1983.
6. Norton, J.A., Doppman, J.L., Cohen, M.J., Harmon, J.W., Maton, P.N., Gardner, J.D., and Jensen, R.T. Prospective study of gastrinoma localization and resection in patients with Zollinger-Ellison syndrome. Ann. Surg. 204:468-479, 1986.
7. Lehy, T., Mignon, M., Cadiot, G., Elouaer-Blanc, L, Ruszniewski, Ph., Lewin, M.J.M., and Bonfils, S. Gastric endocrine cell behavior in Zollinger-Ellison patients upon long-term potent antisecretory treatment. Gastroenterology 96:1029-1040, 1989.
8. Ruszniewski, Ph., Ramdani, A., Cadiot, G., Lehy, T., Mignon, M., and Bonfils, S. Long-term treatment with octreotide in patients with Zollinger-Ellison syndrome. Eur. J. Clin. Invest. 23:296-301, 1993.
9. Norton, J.A., Doppman, J.L., and Jensen, R.T. Cancer of the endocrine system. In: De Vita, V.T., Hellman, S., and Rosenberg, S.A., eds. Cancer, principles and practice of oncology. Philadelphia: Lippincott; 1989, pp. 1269-1344.
10. Norton, J.A. Neuroendocrine tumors of the pancreas and duodenum. Curr. Probl. Surg. 31:81-156, 1994.
11. Fraker, D.L., Norton, J.A., Alexander, R.H., Venzon, D.J., and Jensen, R.T. Surgery in Zollinger-Ellison syndrome alters the natural history of gastrinoma. Ann. Surg. 220:320.330, 1994.
12. Hirschowitz, B.I. Clinical course of nonsurgically treated Zolinger-Ellison syndrome. In: Mignon, M., Jensen, R.T., eds. Endocrine tumors of the pancreas. Basel: Karger, Front. Gastrointest. Res.; 1995, pp. 360-371.
13. Ellison, B.C., Carey, L.C., Sparks, J., O'Dorisio, T., Mekhjian, H.S., Fromkes, J.J., Caldwell, J.H., and Thomas, F.B. Early surgical treatment of gastrinoma. Am. J. Med. 82 (suppl 5B):17-24, 1987.
14. Mignon, M., Ruszniewski Ph., Podevin, P., Sabbagh, L., Cadiot, G., Rigaud, D., and Bonfils, S. Current approach to the management of gastrinoma and insulinoma in adult patients with multiple endocrine neoplasia type I (MEN I). World J. Surg. 17:489-497, 1993.
15. Ruszniewski, Ph., Podevin, P., Cadiot, G., Marmuse, J.P., Mignon, M., Vissuzaine, C., Bonfils, S., and Lehy, T. Clinical, anatomical and evolutive features of patients with the Zollinger-Ellison syndrome combined with type I multiple endocrine neoplasia. Pancreas 8:295-304, 1993.
16. Chaudhry, I., Öberg, K., and Wilander, E., A study of biological behavior based on the expression of a proliferating antigen in neuroendocrine tumors of the digestive system. Tumor Biol. 13:2735, 1992.
17. Metz, D.C., Kuchnio, M., Fraker, D.L., Venzon, D.J., Jaffe, G., Jensen, R.T., and Stetler-Stevenson, M. Flow cytometry and Zollinger-Ellison syndrome : relationship to clinical course. Gastroenterology 105:799-813, 1993.
18. Chaudhry, A. and Öberg, K. Expression of growth factor peptides and adhesion molecules in endocrine pancratic tumors. In: Mignon, M. and Jensen, R.T., eds. Endocrine tumors of the pancreas. Basel: Karger, Front. Gastrointest. Res.; 1995, pp. 132-146.
19. Ruszniewski, Ph., Hochlaf, S., Rougier, P., and Mignon, M. Chimiothérapie intraveineuse par Streptozotocine et 5 Fluoro-Uracile des métastases hépatiques du syndrome de Zollinger-Ellison. Gastroenterology Clin. Biol. 15:393-398, 1991.
20. Weber, H.C., Venzon, D.J., Lin, J.T., Fishbein, V.A., Orbuch, M., Strader, D.B., Gibril, F., Metz, D.C., Fraker, D.L., Norton, J.A., and Jensen, R.T. Determinants of metastatic rate and survival in patients with Zollinger-Ellison syndrome: a prospective long-term study. Gastroenterology 108:1637-1649, 1995.
21. Stabile, B.E. and Passaro, E. Jr. Benign and malignant gastrinoma. Am. J. Surg. 49:144-150, 1985.
22. Howard, T.J., Sawicki, M.P., Stabile, B.E., Watt, P.C., and Passaro, E. Jr. Biologic behavior of sporadic gastrinoma located to the right and left of the superior mesenteric artery. Am. J. Surg. 165:101-106, 1993.
23. Fraker, D.L. and Norton, J.A. The role of surgery in the management of islet cell tumors. In: Jensen, R.T. ed. Gastrointestinal endocrinology. Gastroenterol. Clin. North Am. 18:805-830, 1989.
24. McCarthy, D.M. The place of surgery in the Zollinger-Ellison syndrome. N. Engl. J. Med. 302:1344-1347, 1980.
25. Cadiot, G., Houillier, P., Allouch, A., Paillard, M., Mignon, M. and GRESZE. Interest of the oral calcium tolerance test in the early diagnosis of primary hyperparathyroidism and multiple endocrine neoplasia type I in patients with the Zollinger-Ellison syndrome. Gut. 39:273-278, 1996.
26. Mignon, M., Cadiot, G., Rigaud, D., Ruszniewski, Ph., Jaïs, P., Lehy, T., and Lewin, M.J.M. Management of islet cell tumors in patients with multiple endocrine neoplasia type I. In: Mignon, M., Jensen, R.T., eds. Endocrine tumors of the pancreas. Basel: Karger, Front. Gastrointest. Res.; 1995, pp. 342-359.
27. Norton, J.A., Doppman, J.L., and Jensen, R.T. Curative resection in Zollinger-Ellison syndrome: results of a 10-year prospective study. Ann. Surg. 215:8-18, 1992.
28. Jensen, R.T. and Fraker, D.L. Zollinger-Ellison syndrome. Advances in treatment of gastric hypersecretion and the gastrinoma. JAMA 271:1429-1435, 1994.
29. de Kerviler, E., Cadiot, G., Lebtahi, R., Faraggi, M., Le Guludec, D., Mignon, M., and GRESZE. Somatostatin receptor scintigraphy in forty-eight patients with the Zollinger-Ellison syndrome. Eur. J. Nucl. Med. 21:1191-1197, 1994.
30. Ruszniewski, Ph., Amouyal, P., Amouyal G., Grange, J.D., Mignon, M., Bouché, O., and Bernades, P. Localization of gastrinomas by endoscopie ultrasonography in patients with Zollinger-Ellison syndrome. Surgery 117:629-635, 1995.
31. Gibril, F., Reynolds, J.C., Doppman, J.L., Chen, C.C., Termanini, B., Stewart, C.A., and Jensen, R.T. Does the use of octreoscanning alter management in patients with Zollinger-Ellison syndrome : a prospective study? Gastroenterology 108:A194, 1995.
32. Cadiot, G., Lebtahi, R., Sarda, L., Bonnaud, G., Marmuse, J.P., Vissuzaine, C., Ruszniewski, Ph., Le Guludec, D., and Mignon, M. Preoperative detection of duodenal gastrinomas and peri-pancreatic lymph nodes by somatostatin receptor scintigraphy: Groupe d'Etude du Syndrome de Zollinger-Ellison. Gastroenterology 111:845-854, 1996.
33. Bonnaud, G., Cadiot, G., Lebtahi, R., Sarda, L., Le Guludec, D., and Mignon, M. Implications cliniques de la scintigraphie des récepteurs de la somatostatine (SRS) chez soixante huit malades ayant un syndrome de Zollinger-Ellison. Gastroenterology Clin. Biol. 20:A10, 1996.
34. Nagorney, D.M. and Que, F.G. Cytoreductive hepatic surgery for metastatic gastrointestinal neuroendocrine tumors. In: Mignon, M. and Jensen, R.T., eds. Endocrine tumors of the pancreas. Basel: Karger, Front. Gastrointest. Res ; 1995. pp. 416-430.
35. Arcenas, A.G., Ajani, J.A., Carrasco, H.C., Levin, B., and Wallace, S. Vascular occlusive therapy of pancreatic endocrine tumors metastatic to the liver. In: Mignon, M. and Jensen, R.T., eds. Endocrine tumors of the pancreas. Basel: Karger, Front. Gastrointest. Res.; 1995, pp. 439-450.
36. Ruszniewski, P., Rougier, P., Roche, A., Legmann, P., Sibert, A., Hochlaf, S., Ychou, M., and Mignon, M. Hepatic arterial chemoembolization in patients with liver metastases of endocrine tumors : a prospective phase II study in patients. Cancer 71:2624-2630, 1993.
37. Moertel, C.G., Hanley, G.A., and Johnson, L.A. Streptozotocin alone compared with Streptozotocin alone compared with Streptozotocin plus Fluorouracil in the treatment of advancd islet cell carcinoma. N. Engl. J. Med. 303:1189-1195, 1980.
38. Moertel, C.G., Lefkopoulo, M., Lipsitz, S., Hahn, R.G., and Klaassen, D. Streptozoocin-Doxorubicin, Streptozotocin-Fluorouracil or Chlorozotocin in the treatment of advanced islet-cell carcinoma. N. Engl. J. Med. 326:519-523, 1992.
39. Arnold, R., Neuhaus, C.H., Benning, R., Schwerk, W., and Trautmann, M.E. Sandostatin (SAS) in the control of growth of malignant endocrine GEP tumors. Gastroenterology 102:A256, 1992.
40. Scarpignato, C. Somatostatin analogues in the management of endocrine tumors of the pancreas. In: Mignon, M. and Jensen, R.T., eds. Endocrine tumors of the pancreas. Basel: Karger, Front. Gastrointest. Res. 1995, pp. 385-414.
41. Azoulay, D. and Bismuth, H. Role of liver surgery and transplantation in patients with hepatic metastases from pancreatic endocrine tumors. In: Mignon, M. and Jensen, R.T., eds. Endocrine tumors of the pancreas. Basel: Karger. Front. Gastrointest. Res.; 1995, pp. 461-476.
42. Makowka, L., Tzakis, A.G., Mazzaferrro, V., Teperman, L., Demetris, J., Iwatsuki, S., and Starlz, T.E. Transplantation of the liver for metastatic endocrine tumors of the intestine and pancreas. Surg. Gynecol. Obstet. 168:107-111, 1989.
43. Le Treut, Y.P., Delpero, J.R., Houssin, D., Cherqui, D., Segol, P., Mantion, G., Hannoun, L., Launois, B., Boillot, O., and Domergue, J. Que peut-on attendre de la transplantation hépatique (TH) pour métastases des tumeurs neuro-endocrines (TNE)? Résultats d'une série multicentrique de 28 cas. Gastroenterol. Clin. Biol. 19:A4, 1995.
44. Mignon, M., Ruszniewski, Ph., Hochlaf, S., Sobhani, I., Cadiot, G., Legmann, P., René, E., Bonfils, S., Rigaud, D., and Benhamou, G. Do endocrine liver metastases have intrinsic evolutive features helping decision making for liver transplantation? Gastroenterology 100:A290, 1991.
45. Creutzfeldt, W., Bartsch, H.H., Jacubaschke, U, and Stockmann, F. Treatment of gastrointestinal endocrine tumours with interferon-α and octreotide. Acta Oncolog. 30:529-535, 1991.